Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Stuart

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Nature Communications|December 8, 2022
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomesMatthew A Reyna, David Haan, Marta Paczkowska, et al.
Nature Communications|February 7, 2020
Pathway and network analysis of more than 2500 whole cancer genomesMatthew A Reyna, David Haan, Marta Paczkowska, et al.
Cell Systems|June 19, 2021
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discoveryAllison Creason, David Haan, Kristen Dang, et al.
Developmental Cell|December 15, 2020
Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart DiseaseIrfan S Kathiriya, Kavitha S Rao, Giovanni Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Cancer Cell|January 3, 2025
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature setsKyle Ellrott, Christopher K Wong, Christina Yau, et al.
Nature Biotechnology|January 11, 2020
A community effort to create standards for evaluating tumor subclonal reconstructionAdriana Salcedo, Maxime Tarabichi, Shadrielle Melijah G Espiritu, et al.
Cell|August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originKatherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Nature Communications|December 8, 2022
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomesMatthew A Reyna, David Haan, Marta Paczkowska, et al.
Nature Communications|February 7, 2020
Pathway and network analysis of more than 2500 whole cancer genomesMatthew A Reyna, David Haan, Marta Paczkowska, et al.
Cell Systems|June 19, 2021
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discoveryAllison Creason, David Haan, Kristen Dang, et al.
Developmental Cell|December 15, 2020
Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart DiseaseIrfan S Kathiriya, Kavitha S Rao, Giovanni Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.
NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Cancer Cell|January 3, 2025
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature setsKyle Ellrott, Christopher K Wong, Christina Yau, et al.
Nature Biotechnology|January 11, 2020
A community effort to create standards for evaluating tumor subclonal reconstructionAdriana Salcedo, Maxime Tarabichi, Shadrielle Melijah G Espiritu, et al.
Cell|August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originKatherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Pageof 10